Centro di Referenza Nazionale (CRN) per l’Antibioticoresistenza

Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri
Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri

Molecole per infezioni da Gram positivi (Clinical Breakpoints)

Elenco di possibili molecole antibiotiche per la valutazione della sensibilità in agenti batterici patogeni Gram positivi isolati nel bovino.
Gram +vi$ CLSI VET 01S-Ed 6 CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Beta Lattamici Penicillina Staphylococcus spp (HD) P NP P P NP P NP NP NP P NP P NP NP P
Penicillina (Streptococcus beta haemolytic group HD) P NP NP P NP NP NP NP NP P NP P NP NP P
Penicillina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Cefoxitina^ Staphylococcus (HD) P NP P P NP P NP NP NP NP NP NP NP NP P
(Ceftiofur) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Cefotaxime^ Staphylococcus spp (HD) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Cefotaxime (Streptococcus beta haemolytic group ) NP NP NP P NP NP NP NP NP NP NP NP NP NP NP
Cefotaxime (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
(Fluoro)chinolonici Ciprofloxacin Staphylococcus spp (HD) NP NP NP P p P NP NP NP NP NP NP NP NP P
Ciprofloxacin (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Ciprofloxacin S.agalactie NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Enrofloxacin (Staphylococcus) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Enrofloxacin (Streptococcus ) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Aminoglicosidi (Aminociclitoli) Kanamicina Staphylococcus spp (HD) NP NP NP NP NP NP NP NP NP P NP P NP NP P
(Kanamicina) Streptococcus spp NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gentamicina Staphylococcus spp (HD) P P P P p P NP NP NP P NP P NP NP P
Gentamicina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP NP
(Gentamicina) Streptococcus NP NP NP NP NP NP NP NP NP P NP P NP NP NP
(Gentamicina) Streptococcus agalactiae NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Macrolidi Eritromicina (Staphylococcus HD) P P P P p P NP NP NP P NP P NP NP P
Eritromicina Streptococcus spp (HD) P P P NP NP NP NP NP NP P NP P NP NP NP
Eritromicina (Streptococcus beta haemolityc group) NP NP NP P p P NP NP NP NP NP NP NP NP P
Eritromicina (Corineformi) NP NP NP NP NP NP P P P NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Lincosamidi Clindamicina Streptococcus spp (HD) P P P NP NP NP NP NP NP NP NP NP NP NP NP
Clindamicina Staphylococcus spp (HD) NP NP NP P P P NP NP NP NP NP NP NP NP P
Clindamicina (Streptococcus beta haemolityc group) NP NP NP P P P NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Rifaximine Rifampicina Staphylococcus spp (HD) P P P P P P NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Amfenicoli Cloramfenicolo§ Staphylococcus spp (HD) P P P P P P NP NP NP P NP P NP NP P
Cloramfenicolo§ Streptococcus spp (HD) P P P NP NP NP NP NP NP P NP P NP NP NP
Cloramfenicolo (Streptococcus beta haemolityc group) NP NP NP P P P NP NP NP NP NP NP NP NP NP
Florfenicol (Staphylococcus spp) NP NP NP NP NP NP NP NP NP P NP P NP NP P
Florfenicol (Streptococcus beta haemolytic group) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Sulfonamidi Sulfonamidi (Staphylococcus spp) NP NP NP NP NP NP NP NP NP P NP P NP NP NP
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Trimethoprim Trimethoprim (Staphylococcus) NP NP NP NP NP NP NP NP NP P NP P NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Trimethoprim-sulfamethoxazole Tetraciclina Staphylococcus spp (HD) P NP P P NP P NP NP NP NP NP NP NP NP P
Streptococcus spp NP NP NP NP NP NP NP NP NP P NP P NP NP P
Gram +vi$ CLSI VET 01S-Ed 6 (HD)  CLSI M100 S33 CLSI M45 3rd Ed CA-SFM VET 2023 EUCAST ECOFF 2023
S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥ S≤ I (range) R≥
Tetracicline Tetraciclina Staphylococcus spp (HD) P P P P P P NP NP NP P NP P NP NP P
Tetraciclina Streptococcus spp (HD) P P P P P P NP NP NP P NP P NP NP NP
Tetraciclina (Streptococcus spp beta haemolytic group) NP NP NP NP NP NP NP NP NP NP NP NP NP NP P

Note:

  • P: Clinical breakpoint/Epidemiological cutoff presente
  • NP: Clinical breakpoint/Epidemiological cutoff non presente
  • HD: Human-derived (breakpoints derivati dallo Standard Umano, come da documento CLSI VET)
  • $ Per Staphyloccus aureus, Streptococcus, altri Gram +vi (Trueperella pyogenes)
  • ^ Per Staphylococcus aureus
  • Gli antibiotici tra parentesi sono da considerarsi facoltativi

 


Skip to content